Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expanding the chemical diversity of CK2 inhibitors.
Prudent R, Moucadel V, López-Ramos M, Aci S, Laudet B, Mouawad L, Barette C, Einhorn J, Einhorn C, Denis JN, Bisson G, Schmidt F, Roy S, Lafanechere L, Florent JC, Cochet C. Prudent R, et al. Among authors: moucadel v. Mol Cell Biochem. 2008 Sep;316(1-2):71-85. doi: 10.1007/s11010-008-9828-z. Epub 2008 Jun 18. Mol Cell Biochem. 2008. PMID: 18563535
Salicylaldehyde derivatives as new protein kinase CK2 inhibitors.
Prudent R, López-Ramos M, Moucadel V, Barette C, Grierson D, Mouawad L, Florent JC, Lafanechère L, Schmidt F, Cochet C. Prudent R, et al. Among authors: moucadel v. Biochim Biophys Acta. 2008 Dec;1780(12):1412-20. doi: 10.1016/j.bbagen.2008.06.010. Epub 2008 Jul 7. Biochim Biophys Acta. 2008. PMID: 18674590
In vitro and in vivo assays of protein kinase CK2 activity.
Prudent R, Sautel CF, Moucadel V, Laudet B, Filhol O, Cochet C. Prudent R, et al. Among authors: moucadel v. Methods Enzymol. 2010;485:597-610. doi: 10.1016/B978-0-12-381296-4.00031-2. Methods Enzymol. 2010. PMID: 21050938
Antitumoral activity of allosteric inhibitors of protein kinase CK2.
Moucadel V, Prudent R, Sautel CF, Teillet F, Barette C, Lafanechere L, Receveur-Brechot V, Cochet C. Moucadel V, et al. Oncotarget. 2011 Dec;2(12):997-1010. doi: 10.18632/oncotarget.361. Oncotarget. 2011. PMID: 22184283 Free PMC article.
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
López-Ramos M, Prudent R, Moucadel V, Sautel CF, Barette C, Lafanechère L, Mouawad L, Grierson D, Schmidt F, Florent JC, Filippakopoulos P, Bullock AN, Knapp S, Reiser JB, Cochet C. López-Ramos M, et al. Among authors: moucadel v. FASEB J. 2010 Sep;24(9):3171-85. doi: 10.1096/fj.09-143743. Epub 2010 Apr 16. FASEB J. 2010. PMID: 20400536
Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors.
Kufareva I, Bestgen B, Brear P, Prudent R, Laudet B, Moucadel V, Ettaoussi M, Sautel CF, Krimm I, Engel M, Filhol O, Borgne ML, Lomberget T, Cochet C, Abagyan R. Kufareva I, et al. Among authors: moucadel v. Sci Rep. 2019 Nov 4;9(1):15893. doi: 10.1038/s41598-019-52141-5. Sci Rep. 2019. PMID: 31685885 Free PMC article.
38 results